Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications-Reference-Cited by-同舟云学术

Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications

Published:2009-01 Issue:1 Volume:53 Page:24-34
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Andes David¹,Pascual Andres²,Marchetti Oscar²

Affiliation:

1. Department of Medicine, Section of Infectious Diseases, and Medical Microbiology and Immunology, University of Wisconsin, 600 Highland Ave., Room H4/572, Madison, Wisconsin 53792

2. Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-1011 Lausanne, Switzerland

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00705-08

Reference103 articles.

1. In Vivo Characterization of the Pharmacodynamics of Flucytosine in a Neutropenic Murine Disseminated Candidiasis Model

2. In Vivo Pharmacokinetics and Pharmacodynamics of a New Triazole, Voriconazole, in a Murine Candidiasis Model

3. Pharmacodynamics of a New Triazole, Posaconazole, in a Murine Model of Disseminated Candidiasis

4. Pharmacodynamics of Amphotericin B in a Neutropenic-Mouse Disseminated-Candidiasis Model

5. Characterization and Quantitation of the Pharmacodynamics of Fluconazole in a Neutropenic Murine Disseminated Candidiasis Infection Model

Cited by 427 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the potential risk of oteseconazole and two other tetrazole antifungals to inhibit adrenal steroidogenesis and peripheral metabolism of corticosteroids;Frontiers in Pharmacology;2024-08-08

2. Oral flucytosine dosing in peritoneal dialysis;Antimicrobial Agents and Chemotherapy;2024-08-07

3. WHICH TOOL IS THE BEST GUIDE OPTIMIZE THE VORICONAZOLE DOSAGE: THERAPEUTIC DRUG MONITORING OR CYTOCHROME P450 POLYMORPHISM?;Sağlık Bilimleri Dergisi;2024-07-25

4. An updated list of eumycetoma causative agents and their differences in grain formation and treatment response;Clinical Microbiology Reviews;2024-06-13

5. Updated antimicrobial dosing recommendations for obese patients;Antimicrobial Agents and Chemotherapy;2024-05-02